Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives.
KLHLs
Kelch domain
PPI inhibitors
PROTAC
TPD
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
29 Feb 2024
29 Feb 2024
Historique:
received:
02
01
2024
revised:
07
02
2024
accepted:
19
02
2024
medline:
16
3
2024
pubmed:
16
3
2024
entrez:
15
3
2024
Statut:
aheadofprint
Résumé
Kelch-like proteins (KLHLs) are a large family of BTB-containing proteins. KLHLs function as the substrate adaptor of Cullin 3-RING ligases (CRL3) to recognize substrates. KLHLs play pivotal roles in regulating various physiological and pathological processes by modulating the ubiquitination of their respective substrates. Mounting evidence indicates that mutations or abnormal expression of KLHLs are associated with various human diseases. Targeting KLHLs is a viable strategy for deciphering the KLHLs-related pathways and devising therapies for associated diseases. Here, we comprehensively review the known KLHLs inhibitors to date and the brilliant ideas underlying their development.
Identifiants
pubmed: 38490062
pii: S0223-5234(24)00150-8
doi: 10.1016/j.ejmech.2024.116270
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
116270Informations de copyright
Copyright © 2024 Elsevier Masson SAS. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.